NO330733B1 - Massemarkorer - Google Patents
Massemarkorer Download PDFInfo
- Publication number
- NO330733B1 NO330733B1 NO20024344A NO20024344A NO330733B1 NO 330733 B1 NO330733 B1 NO 330733B1 NO 20024344 A NO20024344 A NO 20024344A NO 20024344 A NO20024344 A NO 20024344A NO 330733 B1 NO330733 B1 NO 330733B1
- Authority
- NO
- Norway
- Prior art keywords
- mass
- markers
- marker
- accordance
- arrangement
- Prior art date
Links
- 239000003550 marker Substances 0.000 claims abstract description 263
- 238000004949 mass spectrometry Methods 0.000 claims abstract description 63
- 238000010606 normalization Methods 0.000 claims abstract description 28
- 238000006062 fragmentation reaction Methods 0.000 claims abstract description 25
- 238000013467 fragmentation Methods 0.000 claims abstract description 24
- 238000000034 method Methods 0.000 claims description 242
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 224
- 108090000623 proteins and genes Proteins 0.000 claims description 173
- 102000004169 proteins and genes Human genes 0.000 claims description 173
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 171
- 239000000523 sample Substances 0.000 claims description 159
- 150000002500 ions Chemical class 0.000 claims description 138
- 239000012634 fragment Substances 0.000 claims description 115
- 150000007523 nucleic acids Chemical class 0.000 claims description 77
- 108020004707 nucleic acids Proteins 0.000 claims description 63
- 102000039446 nucleic acids Human genes 0.000 claims description 63
- 238000003776 cleavage reaction Methods 0.000 claims description 61
- 230000007017 scission Effects 0.000 claims description 60
- 229920001184 polypeptide Polymers 0.000 claims description 53
- 238000004458 analytical method Methods 0.000 claims description 50
- 238000001819 mass spectrum Methods 0.000 claims description 47
- 239000012491 analyte Substances 0.000 claims description 45
- 239000000203 mixture Substances 0.000 claims description 34
- 238000002372 labelling Methods 0.000 claims description 30
- 108020004635 Complementary DNA Proteins 0.000 claims description 29
- 108091034117 Oligonucleotide Proteins 0.000 claims description 28
- 238000000926 separation method Methods 0.000 claims description 28
- 238000001514 detection method Methods 0.000 claims description 24
- 239000003795 chemical substances by application Substances 0.000 claims description 23
- 239000002299 complementary DNA Substances 0.000 claims description 22
- 125000004122 cyclic group Chemical group 0.000 claims description 19
- 238000012163 sequencing technique Methods 0.000 claims description 18
- 238000001502 gel electrophoresis Methods 0.000 claims description 16
- 108020004414 DNA Proteins 0.000 claims description 15
- 238000006243 chemical reaction Methods 0.000 claims description 15
- 125000001424 substituent group Chemical group 0.000 claims description 15
- 125000001153 fluoro group Chemical group F* 0.000 claims description 14
- 239000002773 nucleotide Substances 0.000 claims description 14
- 125000003729 nucleotide group Chemical group 0.000 claims description 14
- 125000003118 aryl group Chemical group 0.000 claims description 13
- 102000007079 Peptide Fragments Human genes 0.000 claims description 12
- 108010033276 Peptide Fragments Proteins 0.000 claims description 12
- 150000001413 amino acids Chemical class 0.000 claims description 12
- 238000009396 hybridization Methods 0.000 claims description 12
- 125000000623 heterocyclic group Chemical group 0.000 claims description 11
- 238000002955 isolation Methods 0.000 claims description 11
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 10
- 125000001931 aliphatic group Chemical group 0.000 claims description 9
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 9
- 229960002685 biotin Drugs 0.000 claims description 8
- 239000011616 biotin Substances 0.000 claims description 8
- 235000020958 biotin Nutrition 0.000 claims description 7
- 238000005251 capillar electrophoresis Methods 0.000 claims description 7
- 238000010494 dissociation reaction Methods 0.000 claims description 7
- 230000005593 dissociations Effects 0.000 claims description 7
- 238000001962 electrophoresis Methods 0.000 claims description 7
- 229910052739 hydrogen Inorganic materials 0.000 claims description 7
- 239000001257 hydrogen Substances 0.000 claims description 7
- -1 N-methyl-pyridyl group Chemical group 0.000 claims description 6
- 238000010195 expression analysis Methods 0.000 claims description 6
- 230000000155 isotopic effect Effects 0.000 claims description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
- 150000001720 carbohydrates Chemical class 0.000 claims description 5
- 230000000295 complement effect Effects 0.000 claims description 5
- 238000012544 monitoring process Methods 0.000 claims description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 5
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 4
- 238000004587 chromatography analysis Methods 0.000 claims description 4
- 238000011223 gene expression profiling Methods 0.000 claims description 4
- 102000053602 DNA Human genes 0.000 claims description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 3
- 108020004682 Single-Stranded DNA Proteins 0.000 claims description 3
- 108091005601 modified peptides Proteins 0.000 claims description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 3
- 102000003960 Ligases Human genes 0.000 claims description 2
- 108090000364 Ligases Proteins 0.000 claims description 2
- 238000001042 affinity chromatography Methods 0.000 claims description 2
- 230000006287 biotinylation Effects 0.000 claims description 2
- 238000007413 biotinylation Methods 0.000 claims description 2
- 238000004850 capillary HPLC Methods 0.000 claims description 2
- 238000001818 capillary gel electrophoresis Methods 0.000 claims description 2
- 230000026731 phosphorylation Effects 0.000 claims description 2
- 238000006366 phosphorylation reaction Methods 0.000 claims description 2
- 230000003213 activating effect Effects 0.000 claims 1
- 125000005013 aryl ether group Chemical group 0.000 claims 1
- 235000018102 proteins Nutrition 0.000 description 153
- 125000005647 linker group Chemical group 0.000 description 40
- 239000000499 gel Substances 0.000 description 39
- 238000001228 spectrum Methods 0.000 description 31
- 238000001360 collision-induced dissociation Methods 0.000 description 24
- 238000010804 cDNA synthesis Methods 0.000 description 20
- 239000003153 chemical reaction reagent Substances 0.000 description 20
- 239000000047 product Substances 0.000 description 20
- 150000001875 compounds Chemical class 0.000 description 19
- 150000001412 amines Chemical class 0.000 description 16
- 101800001415 Bri23 peptide Proteins 0.000 description 15
- 102400000107 C-terminal peptide Human genes 0.000 description 15
- 101800000655 C-terminal peptide Proteins 0.000 description 15
- 239000007787 solid Substances 0.000 description 15
- 125000003277 amino group Chemical group 0.000 description 14
- 238000004885 tandem mass spectrometry Methods 0.000 description 14
- 150000003573 thiols Chemical class 0.000 description 14
- 230000008569 process Effects 0.000 description 12
- 239000007789 gas Substances 0.000 description 10
- 150000002430 hydrocarbons Chemical group 0.000 description 10
- 238000004811 liquid chromatography Methods 0.000 description 10
- 238000002553 single reaction monitoring Methods 0.000 description 10
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 230000035945 sensitivity Effects 0.000 description 8
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 7
- 125000004429 atom Chemical group 0.000 description 7
- 238000013375 chromatographic separation Methods 0.000 description 7
- 239000011521 glass Substances 0.000 description 7
- 108091008146 restriction endonucleases Proteins 0.000 description 7
- 238000002098 selective ion monitoring Methods 0.000 description 7
- 239000007790 solid phase Substances 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 6
- 239000004472 Lysine Substances 0.000 description 6
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical class C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 description 6
- 229940088598 enzyme Drugs 0.000 description 6
- 230000014509 gene expression Effects 0.000 description 6
- 239000007791 liquid phase Substances 0.000 description 6
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 5
- 108090000631 Trypsin Proteins 0.000 description 5
- 102000004142 Trypsin Human genes 0.000 description 5
- 230000003321 amplification Effects 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 210000004899 c-terminal region Anatomy 0.000 description 5
- 125000004432 carbon atom Chemical group C* 0.000 description 5
- 238000010828 elution Methods 0.000 description 5
- 229930195733 hydrocarbon Natural products 0.000 description 5
- 238000001155 isoelectric focusing Methods 0.000 description 5
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 5
- 108020004999 messenger RNA Proteins 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000012588 trypsin Substances 0.000 description 5
- 239000004215 Carbon black (E152) Substances 0.000 description 4
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 150000008378 aryl ethers Chemical class 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 4
- 150000001793 charged compounds Chemical class 0.000 description 4
- 235000018417 cysteine Nutrition 0.000 description 4
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 4
- 239000007850 fluorescent dye Substances 0.000 description 4
- 229910052731 fluorine Inorganic materials 0.000 description 4
- 125000000524 functional group Chemical group 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 239000003446 ligand Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000006467 substitution reaction Methods 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 108010059378 Endopeptidases Proteins 0.000 description 3
- 102000005593 Endopeptidases Human genes 0.000 description 3
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 230000002776 aggregation Effects 0.000 description 3
- 238000004220 aggregation Methods 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 238000000738 capillary electrophoresis-mass spectrometry Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 125000000753 cycloalkyl group Chemical group 0.000 description 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical group C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 125000000962 organic group Chemical group 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- DCWXELXMIBXGTH-QMMMGPOBSA-N phosphonotyrosine Chemical group OC(=O)[C@@H](N)CC1=CC=C(OP(O)(O)=O)C=C1 DCWXELXMIBXGTH-QMMMGPOBSA-N 0.000 description 3
- DCWXELXMIBXGTH-UHFFFAOYSA-N phosphotyrosine Chemical compound OC(=O)C(N)CC1=CC=C(OP(O)(O)=O)C=C1 DCWXELXMIBXGTH-UHFFFAOYSA-N 0.000 description 3
- 229920000570 polyether Polymers 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000007480 sanger sequencing Methods 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 229940104230 thymidine Drugs 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 description 2
- WUIJTQZXUURFQU-UHFFFAOYSA-N 1-methylsulfonylethene Chemical compound CS(=O)(=O)C=C WUIJTQZXUURFQU-UHFFFAOYSA-N 0.000 description 2
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Chemical compound C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 2
- 125000004042 4-aminobutyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])N([H])[H] 0.000 description 2
- XSXHTPJCSHZYFJ-MNXVOIDGSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-n-[(5s)-5-amino-6-hydrazinyl-6-oxohexyl]pentanamide Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)NCCCC[C@H](N)C(=O)NN)SC[C@@H]21 XSXHTPJCSHZYFJ-MNXVOIDGSA-N 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 2
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 2
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 2
- 238000001712 DNA sequencing Methods 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- 101001018085 Lysobacter enzymogenes Lysyl endopeptidase Proteins 0.000 description 2
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 2
- 239000004721 Polyphenylene oxide Substances 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- 108090000190 Thrombin Proteins 0.000 description 2
- 229960000643 adenine Drugs 0.000 description 2
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 2
- 238000003491 array Methods 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 2
- 230000001588 bifunctional effect Effects 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 229910052796 boron Inorganic materials 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 210000004900 c-terminal fragment Anatomy 0.000 description 2
- 238000005515 capillary zone electrophoresis Methods 0.000 description 2
- 125000000837 carbohydrate group Chemical group 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 229940104302 cytosine Drugs 0.000 description 2
- 239000003398 denaturant Substances 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 2
- 238000001215 fluorescent labelling Methods 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 229940029575 guanosine Drugs 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 238000005040 ion trap Methods 0.000 description 2
- 238000000752 ionisation method Methods 0.000 description 2
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 210000004898 n-terminal fragment Anatomy 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 239000002853 nucleic acid probe Substances 0.000 description 2
- 230000000269 nucleophilic effect Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- 238000005191 phase separation Methods 0.000 description 2
- 125000004437 phosphorous atom Chemical group 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 229920000090 poly(aryl ether) Polymers 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 108091033319 polynucleotide Proteins 0.000 description 2
- 102000040430 polynucleotide Human genes 0.000 description 2
- 239000002157 polynucleotide Substances 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 150000003141 primary amines Chemical class 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 125000004076 pyridyl group Chemical group 0.000 description 2
- 238000011896 sensitive detection Methods 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 238000004611 spectroscopical analysis Methods 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 125000004434 sulfur atom Chemical group 0.000 description 2
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 2
- 229960004072 thrombin Drugs 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- KGIGUEBEKRSTEW-UHFFFAOYSA-N 2-vinylpyridine Chemical compound C=CC1=CC=CC=N1 KGIGUEBEKRSTEW-UHFFFAOYSA-N 0.000 description 1
- 125000003974 3-carbamimidamidopropyl group Chemical group C(N)(=N)NCCC* 0.000 description 1
- UUEWCQRISZBELL-UHFFFAOYSA-N 3-trimethoxysilylpropane-1-thiol Chemical compound CO[Si](OC)(OC)CCCS UUEWCQRISZBELL-UHFFFAOYSA-N 0.000 description 1
- 125000003143 4-hydroxybenzyl group Chemical group [H]C([*])([H])C1=C([H])C([H])=C(O[H])C([H])=C1[H] 0.000 description 1
- SUTWPJHCRAITLU-UHFFFAOYSA-N 6-aminohexan-1-ol Chemical compound NCCCCCCO SUTWPJHCRAITLU-UHFFFAOYSA-N 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- BXTVQNYQYUTQAZ-UHFFFAOYSA-N BNPS-skatole Chemical compound N=1C2=CC=CC=C2C(C)(Br)C=1SC1=CC=CC=C1[N+]([O-])=O BXTVQNYQYUTQAZ-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 125000001433 C-terminal amino-acid group Chemical group 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 239000005046 Chlorosilane Substances 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 241000863030 Lysobacter enzymogenes Species 0.000 description 1
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 1
- 102400000108 N-terminal peptide Human genes 0.000 description 1
- 101800000597 N-terminal peptide Proteins 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 108010030544 Peptidyl-Lys metalloendopeptidase Proteins 0.000 description 1
- 101710118538 Protease Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- 108010064978 Type II Site-Specific Deoxyribonucleases Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- 238000001261 affinity purification Methods 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 150000001336 alkenes Chemical group 0.000 description 1
- 150000001345 alkine derivatives Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- WGQKYBSKWIADBV-UHFFFAOYSA-N aminomethyl benzene Natural products NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 150000001499 aryl bromides Chemical class 0.000 description 1
- 238000000376 autoradiography Methods 0.000 description 1
- RFRXIWQYSOIBDI-UHFFFAOYSA-N benzarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC=C(O)C=C1 RFRXIWQYSOIBDI-UHFFFAOYSA-N 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 150000001615 biotins Chemical class 0.000 description 1
- 150000001244 carboxylic acid anhydrides Chemical class 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 238000012412 chemical coupling Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- KOPOQZFJUQMUML-UHFFFAOYSA-N chlorosilane Chemical compound Cl[SiH3] KOPOQZFJUQMUML-UHFFFAOYSA-N 0.000 description 1
- 238000011210 chromatographic step Methods 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 150000003983 crown ethers Chemical class 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- 150000001945 cysteines Chemical class 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 229910052805 deuterium Inorganic materials 0.000 description 1
- 239000005546 dideoxynucleotide Substances 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000004141 dimensional analysis Methods 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000005264 electron capture Effects 0.000 description 1
- 238000000132 electrospray ionisation Methods 0.000 description 1
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- RMBPEFMHABBEKP-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2C3=C[CH]C=CC3=CC2=C1 RMBPEFMHABBEKP-UHFFFAOYSA-N 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229960000789 guanidine hydrochloride Drugs 0.000 description 1
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000000879 imine group Chemical group 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- JDNTWHVOXJZDSN-UHFFFAOYSA-N iodoacetic acid Chemical compound OC(=O)CI JDNTWHVOXJZDSN-UHFFFAOYSA-N 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 150000002540 isothiocyanates Chemical class 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 1
- 108091005573 modified proteins Proteins 0.000 description 1
- 102000035118 modified proteins Human genes 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 238000000329 molecular dynamics simulation Methods 0.000 description 1
- 239000012038 nucleophile Substances 0.000 description 1
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N o-biphenylenemethane Natural products C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 1
- 238000002515 oligonucleotide synthesis Methods 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 238000002542 parent ion scan Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000000955 peptide mass fingerprinting Methods 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 238000002541 precursor ion scan Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 125000003186 propargylic group Chemical group 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000000163 radioactive labelling Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 125000006853 reporter group Chemical group 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000010187 selection method Methods 0.000 description 1
- 125000005629 sialic acid group Chemical group 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 229940035637 spectrum-4 Drugs 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- VLZHRJNAIQPARN-UHFFFAOYSA-M stannyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)O[SnH3] VLZHRJNAIQPARN-UHFFFAOYSA-M 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical group O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 125000002653 sulfanylmethyl group Chemical group [H]SC([H])([H])[*] 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical class ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 150000007970 thio esters Chemical class 0.000 description 1
- 125000000101 thioether group Chemical group 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 238000006177 thiolation reaction Methods 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- 150000003606 tin compounds Chemical class 0.000 description 1
- 229960001322 trypsin Drugs 0.000 description 1
- 125000000430 tryptophan group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12 0.000 description 1
- 150000003672 ureas Chemical class 0.000 description 1
- 150000003673 urethanes Chemical class 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
- C12Q1/6872—Methods for sequencing involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2458/00—Labels used in chemical analysis of biological material
- G01N2458/15—Non-radioactive isotope labels, e.g. for detection by mass spectrometry
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/13—Tracers or tags
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Food Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Inorganic Insulating Materials (AREA)
- Liquid Crystal Substances (AREA)
- Glass Compositions (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Compression Or Coding Systems Of Tv Signals (AREA)
- Road Signs Or Road Markings (AREA)
- Luminescent Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0006141.6A GB0006141D0 (en) | 2000-03-14 | 2000-03-14 | Mass labels |
PCT/GB2001/001122 WO2001068664A2 (en) | 2000-03-14 | 2001-03-14 | Mass labels |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20024344D0 NO20024344D0 (no) | 2002-09-12 |
NO20024344L NO20024344L (no) | 2002-11-14 |
NO330733B1 true NO330733B1 (no) | 2011-06-27 |
Family
ID=9887608
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20024344A NO330733B1 (no) | 2000-03-14 | 2002-09-12 | Massemarkorer |
Country Status (15)
Country | Link |
---|---|
US (3) | US7294456B2 (xx) |
EP (2) | EP1275004B1 (xx) |
JP (1) | JP4608171B2 (xx) |
CN (2) | CN1427953B (xx) |
AT (1) | ATE364841T1 (xx) |
AU (2) | AU2001240834B2 (xx) |
CA (1) | CA2403114C (xx) |
DE (1) | DE60128900T2 (xx) |
DK (1) | DK1275004T3 (xx) |
ES (2) | ES2389510T3 (xx) |
GB (1) | GB0006141D0 (xx) |
IL (2) | IL151732A0 (xx) |
NO (1) | NO330733B1 (xx) |
PT (1) | PT1275004E (xx) |
WO (1) | WO2001068664A2 (xx) |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1002128A1 (en) * | 1997-07-11 | 2000-05-24 | Brax Genomics Limited | Characterising nucleic acids |
JP2004506900A (ja) * | 2000-08-11 | 2004-03-04 | アジリックス・コーポレイション | 超高感度検出システム |
JP2005509134A (ja) * | 2001-04-03 | 2005-04-07 | サーモ フィニガン エルエルシー | 複合ペプチド混合物の単純化方法およびキット |
WO2003025576A2 (en) * | 2001-09-14 | 2003-03-27 | Xzillion Gmbh & Co. Kg | Mass labels |
AU2002365271B2 (en) * | 2001-11-06 | 2008-12-11 | Agilix Corporation | Sensitive coded detection systems |
ATE427495T1 (de) * | 2001-12-11 | 2009-04-15 | Univ New Jersey Med | Diagnoseverfahren fur proteinprofilierung |
CA2480836C (en) | 2002-04-04 | 2015-06-09 | Xzillion Gmbh & Co. Kg | Method for characterising analytes |
US20040219685A1 (en) | 2003-01-30 | 2004-11-04 | Applera Corporation | Methods and mixtures pertaining to analyte determination using electrophilic labeling reagents |
GB0306756D0 (en) | 2003-03-24 | 2003-04-30 | Xzillion Gmbh & Co Kg | Mass labels |
JP2007515625A (ja) * | 2003-11-14 | 2007-06-14 | アイアールエム エルエルシー | 生物由来サンプルの選択的処理のためのフルオラス標識化 |
US7355045B2 (en) | 2004-01-05 | 2008-04-08 | Applera Corporation | Isotopically enriched N-substituted piperazine acetic acids and methods for the preparation thereof |
US20050148087A1 (en) | 2004-01-05 | 2005-07-07 | Applera Corporation | Isobarically labeled analytes and fragment ions derived therefrom |
US7307169B2 (en) | 2004-01-05 | 2007-12-11 | Applera Corporation | Isotopically enriched N-substituted piperazines and methods for the preparation thereof |
WO2005085869A2 (en) * | 2004-03-01 | 2005-09-15 | Applera Corporation | Determination of analyte characteristics based upon binding properties |
ES2549077T3 (es) * | 2004-04-07 | 2015-10-22 | Genentech, Inc. | Espectrometría de masas de conjugados de anticuerpos |
WO2005114700A2 (en) * | 2004-05-19 | 2005-12-01 | Applera Corporation | Expression quantification using mass spectrometry |
US20070054345A1 (en) * | 2004-05-19 | 2007-03-08 | Hunter Christie L | Expression quantification using mass spectrometry |
US20080206737A1 (en) * | 2004-05-19 | 2008-08-28 | Hunter Christie L | Expression quantification using mass spectrometry |
EP1756307A1 (en) | 2004-05-20 | 2007-02-28 | Trillion Genomics Limited | Use of mass labelled probes to detect target nucleic acids using mass spectrometry |
WO2006017208A1 (en) * | 2004-07-12 | 2006-02-16 | Applera Corporation | Mass tags for quantitative analyses |
US20070048752A1 (en) * | 2004-07-12 | 2007-03-01 | Applera Corporation | Mass tags for quantitative analyses |
EP1778874B1 (en) | 2004-07-30 | 2011-11-23 | Adeza Biomedical Corporation | Oncofetal fibronectin as a marker for cervical cancer |
JP2008529035A (ja) * | 2005-02-03 | 2008-07-31 | パーキンエルマー エルエーエス,インク. | 多次元シグナルを用いる超高感度検出システム |
US20070037286A1 (en) * | 2005-02-09 | 2007-02-15 | Subhasish Purkayastha | Thyroxine-containing compound analysis methods |
US20060183238A1 (en) | 2005-02-09 | 2006-08-17 | Applera Corporation | Amine-containing compound analysis methods |
GB0515323D0 (en) * | 2005-07-26 | 2005-08-31 | Electrophoretics Ltd | Mass labels |
JP4651094B2 (ja) * | 2005-08-09 | 2011-03-16 | キヤノン株式会社 | 標識されたプローブ結合物体、その製造方法、及びその利用方法 |
GB0518585D0 (en) * | 2005-09-12 | 2005-10-19 | Electrophoretics Ltd | Mass labels |
WO2007078229A1 (en) * | 2006-01-05 | 2007-07-12 | Ge Healthcare Bio-Sciences Ab | Kit and method for mass labelling |
US7902345B2 (en) * | 2006-12-05 | 2011-03-08 | Sequenom, Inc. | Detection and quantification of biomolecules using mass spectrometry |
US8133701B2 (en) * | 2006-12-05 | 2012-03-13 | Sequenom, Inc. | Detection and quantification of biomolecules using mass spectrometry |
US7728287B2 (en) * | 2007-03-01 | 2010-06-01 | Lawrence Livermore National Security, Llc | Imaging mass spectrometer with mass tags |
GB0704764D0 (en) | 2007-03-12 | 2007-04-18 | Electrophoretics Ltd | Isobarically labelled reagents and methods of their use |
ATE549419T1 (de) | 2007-08-29 | 2012-03-15 | Sequenom Inc | Verfahren und zusammensetzungen für die universelle grössenspezifische polymerasekettenreaktion |
GB0809488D0 (en) * | 2008-05-23 | 2008-07-02 | Electrophoretics Ltd | Mass spectrometric analysis |
GB0811574D0 (en) * | 2008-06-24 | 2008-07-30 | Trillion Genomics Ltd | Characterising planar samples by mass spectrometry |
CA2742272C (en) * | 2008-10-30 | 2018-05-29 | Sequenom, Inc. | Products and processes for multiplex nucleic acid identification |
EP2406634A4 (en) | 2009-03-10 | 2013-06-19 | Univ Maryland | ISOBARE DEUTERIUM REACTIVE MARKERS USED FOR QUANTITATIVE ANALYZES |
GB0916881D0 (en) * | 2009-09-25 | 2009-11-11 | Electrophoretics Ltd | Mass labels |
GB0921665D0 (en) | 2009-12-10 | 2010-01-27 | Trillion Genomics Ltd | Phobes |
US8309359B2 (en) * | 2010-01-15 | 2012-11-13 | California Institute Of Technology | Isobaric tags for analyte detection and quantification |
JP5855581B2 (ja) * | 2010-01-22 | 2016-02-09 | ディーエイチ テクノロジーズ デベロップメント プライベート リミテッド | 小分子の同時的な定量および同定のための質量タグ試薬 |
US9291597B2 (en) | 2010-07-02 | 2016-03-22 | Ventana Medical Systems, Inc. | Detecting targets using mass tags and mass spectrometry |
US8461987B2 (en) * | 2010-11-17 | 2013-06-11 | Theodosios Kountotsis | System and method for performing chemical analysis of fingerprints for providing at least one response |
WO2012159089A1 (en) * | 2011-05-19 | 2012-11-22 | Sequenom, Inc. | Products and processes for multiplex nucleic acid identification |
US9388132B2 (en) | 2011-09-15 | 2016-07-12 | Wisconsin Alumni Research Foundation | Isobaric tandem mass tags for quantitative proteomics and peptidomics |
EP2847594B1 (en) * | 2012-05-10 | 2016-06-22 | Thermo Finnigan LLC | Method for highly multiplexed quantitation of peptides by mass spectrometry and labeling reagent sets therefor |
US9366678B2 (en) | 2012-10-25 | 2016-06-14 | Wisconsin Alumni Research Foundation | Neutron encoded mass tags for analyte quantification |
US9594074B2 (en) * | 2012-12-26 | 2017-03-14 | Quest Diagnostics Investments Incorporated | C peptide detection by mass spectrometry |
JP5569761B1 (ja) * | 2013-03-29 | 2014-08-13 | シャープ株式会社 | 分析方法 |
GB201308765D0 (en) * | 2013-05-15 | 2013-06-26 | Electrophoretics Ltd | Mass Tag Reagents |
GB201322567D0 (en) | 2013-12-19 | 2014-02-05 | Electrophoretics Ltd | Mass labels |
GB201410523D0 (en) | 2014-06-12 | 2014-07-30 | Electrophoretics Ltd | Mass labels |
EP3286328B1 (en) | 2015-04-24 | 2020-10-21 | Agena Bioscience, Inc. | Multiplex methods for detection and quantification of minor variants |
US10233489B2 (en) | 2015-04-24 | 2019-03-19 | Agena Bioscience, Inc. | Multiplexed method for the identification and quantitation of minor alleles and polymorphisms |
GB201511508D0 (en) * | 2015-07-01 | 2015-08-12 | Ge Healthcare Bio Sciences Ab | Method for determining a size of biomolecules |
GB201521903D0 (en) | 2015-12-11 | 2016-01-27 | Electrophoretics Ltd | Isorbaric mass labels |
GB201521919D0 (en) | 2015-12-11 | 2016-01-27 | Electrophoretics Ltd | Isobaric mass labels |
US20190120793A1 (en) * | 2016-02-22 | 2019-04-25 | Shimadzu Corporation | Method for analyzing sialyl sugar chain |
WO2018115243A1 (en) * | 2016-12-23 | 2018-06-28 | Roche Diagnostics Gmbh | Method for tracking a sample identity during a process in an analysis system |
JP7046070B2 (ja) | 2016-12-23 | 2022-04-01 | エフ.ホフマン-ラ ロシュ アーゲー | 分析系におけるプロセス中に試薬を同定するための方法 |
JP7051871B2 (ja) * | 2016-12-23 | 2022-04-11 | エフ.ホフマン-ラ ロシュ アーゲー | 分析系におけるプロセス中に試薬を同定するための方法 |
WO2020191291A1 (en) * | 2019-03-21 | 2020-09-24 | C2Sense, Inc. | Systems for detection of volatile ions and related methods |
GB201907792D0 (en) | 2019-05-31 | 2019-07-17 | Thermo Fisher Scient Bremen Gmbh | Deconvolution of mass spectromerty data |
EP4047371A1 (en) | 2021-02-18 | 2022-08-24 | Thermo Fisher Scientific (Bremen) GmbH | Method and apparatus for analysing samples of biomolecules using mass spectrometry with data-independent acquisition |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5800992A (en) * | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
US5252296A (en) * | 1990-05-15 | 1993-10-12 | Chiron Corporation | Method and apparatus for biopolymer synthesis |
GB9315847D0 (en) | 1993-07-30 | 1993-09-15 | Isis Innovation | Tag reagent and assay method |
JPH08145948A (ja) * | 1994-11-16 | 1996-06-07 | Sumitomo Chem Co Ltd | 還元性オリゴ糖の質量分析法 |
US6027890A (en) * | 1996-01-23 | 2000-02-22 | Rapigene, Inc. | Methods and compositions for enhancing sensitivity in the analysis of biological-based assays |
ATE191750T1 (de) | 1996-01-23 | 2000-04-15 | Rapigene Inc | Verfahren und zusammenstellungen zur sequenzbestimmung von nukleinsäuremolekulen |
AU2217597A (en) * | 1996-03-18 | 1997-10-22 | Sequenom, Inc. | Dna sequencing by mass spectrometry |
HUP9901560A3 (en) | 1996-04-08 | 2000-09-28 | Glaxo Group Ltd | Mass-based encoding and qualitative analysis of combinatorial libraries |
GB9620769D0 (en) | 1996-10-04 | 1996-11-20 | Brax Genomics Ltd | Nucleic acid sequencing |
JPH10123096A (ja) * | 1996-10-22 | 1998-05-15 | Sumitomo Chem Co Ltd | シアロオリゴ糖の質量分析法 |
AU5794498A (en) | 1996-12-10 | 1998-07-03 | Genetrace Systems, Inc. | Releasable nonvolatile mass-label molecules |
ATE340869T1 (de) * | 1997-01-15 | 2006-10-15 | Xzillion Gmbh & Co Kg | Massenmarkierte hybridisierungssonden |
EP1002128A1 (en) | 1997-07-11 | 2000-05-24 | Brax Genomics Limited | Characterising nucleic acids |
GB9718921D0 (en) * | 1997-09-05 | 1997-11-12 | Brax Genomics Ltd | Catalytically generated mass labels |
CA2303790A1 (en) | 1997-09-15 | 1999-03-25 | Brax Group Limited | Characterising nucleic acid by mass spectrometry |
FI106679B (fi) * | 1997-12-16 | 2001-03-15 | Nokia Networks Oy | Optinen vastaanotin |
GB9815163D0 (en) * | 1998-07-13 | 1998-09-09 | Brax Genomics Ltd | Compounds |
GB9823646D0 (en) * | 1997-12-19 | 1998-12-23 | Brax Genomics Ltd | Compounds for mass spectrometry |
JP2004506900A (ja) * | 2000-08-11 | 2004-03-04 | アジリックス・コーポレイション | 超高感度検出システム |
US9722639B2 (en) | 2013-05-01 | 2017-08-01 | Qorvo Us, Inc. | Carrier aggregation arrangements for mobile devices |
US20140377016A1 (en) | 2013-06-21 | 2014-12-25 | Pavestone, LLC | Retaining wall block system with modulating heights, widths, and included angles |
US9187086B1 (en) | 2014-05-22 | 2015-11-17 | Ford Global Technologies, Llc | Clutch control to enter powersplit hybrid powertrain parallel mode |
US9701070B2 (en) | 2014-11-06 | 2017-07-11 | Lockheed Martin Corporation | Mandrel forming for discrete wing skin stiffeners |
-
2000
- 2000-03-14 GB GBGB0006141.6A patent/GB0006141D0/en not_active Ceased
-
2001
- 2001-03-14 DE DE60128900T patent/DE60128900T2/de not_active Expired - Lifetime
- 2001-03-14 ES ES07075074T patent/ES2389510T3/es not_active Expired - Lifetime
- 2001-03-14 PT PT01911912T patent/PT1275004E/pt unknown
- 2001-03-14 CN CN018090419A patent/CN1427953B/zh not_active Expired - Lifetime
- 2001-03-14 US US10/221,666 patent/US7294456B2/en not_active Expired - Lifetime
- 2001-03-14 AU AU2001240834A patent/AU2001240834B2/en not_active Expired
- 2001-03-14 IL IL15173201A patent/IL151732A0/xx unknown
- 2001-03-14 DK DK01911912T patent/DK1275004T3/da active
- 2001-03-14 CN CN2012102853264A patent/CN102839213A/zh active Pending
- 2001-03-14 CA CA002403114A patent/CA2403114C/en not_active Expired - Lifetime
- 2001-03-14 ES ES01911912T patent/ES2287104T3/es not_active Expired - Lifetime
- 2001-03-14 EP EP01911912A patent/EP1275004B1/en not_active Expired - Lifetime
- 2001-03-14 EP EP07075074A patent/EP1806586B1/en not_active Expired - Lifetime
- 2001-03-14 AU AU4083401A patent/AU4083401A/xx active Pending
- 2001-03-14 JP JP2001567754A patent/JP4608171B2/ja not_active Expired - Lifetime
- 2001-03-14 AT AT01911912T patent/ATE364841T1/de active
- 2001-03-14 WO PCT/GB2001/001122 patent/WO2001068664A2/en active IP Right Grant
-
2002
- 2002-09-12 IL IL151732A patent/IL151732A/en active IP Right Grant
- 2002-09-12 NO NO20024344A patent/NO330733B1/no not_active IP Right Cessation
-
2007
- 2007-08-20 US US11/841,707 patent/US7816304B2/en not_active Expired - Lifetime
- 2007-08-20 US US11/894,735 patent/US7825069B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CN1427953A (zh) | 2003-07-02 |
NO20024344D0 (no) | 2002-09-12 |
EP1275004B1 (en) | 2007-06-13 |
US7294456B2 (en) | 2007-11-13 |
EP1806586B1 (en) | 2012-08-15 |
EP1275004A2 (en) | 2003-01-15 |
GB0006141D0 (en) | 2000-05-03 |
US20080145850A1 (en) | 2008-06-19 |
US20030194717A1 (en) | 2003-10-16 |
US7825069B2 (en) | 2010-11-02 |
CA2403114A1 (en) | 2001-09-20 |
PT1275004E (pt) | 2007-08-14 |
JP2003529059A (ja) | 2003-09-30 |
DE60128900T2 (de) | 2008-02-07 |
CN102839213A (zh) | 2012-12-26 |
WO2001068664A2 (en) | 2001-09-20 |
JP4608171B2 (ja) | 2011-01-05 |
NO20024344L (no) | 2002-11-14 |
EP1806586A1 (en) | 2007-07-11 |
DE60128900D1 (de) | 2007-07-26 |
IL151732A0 (en) | 2003-04-10 |
AU4083401A (en) | 2001-09-24 |
ATE364841T1 (de) | 2007-07-15 |
CA2403114C (en) | 2007-07-31 |
ES2389510T3 (es) | 2012-10-26 |
US7816304B2 (en) | 2010-10-19 |
WO2001068664A3 (en) | 2002-03-21 |
CN1427953B (zh) | 2012-08-29 |
AU2001240834B2 (en) | 2005-11-17 |
IL151732A (en) | 2008-11-03 |
ES2287104T3 (es) | 2007-12-16 |
DK1275004T3 (da) | 2007-10-15 |
US20080167197A1 (en) | 2008-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO330733B1 (no) | Massemarkorer | |
AU2001240834A1 (en) | Mass labels | |
US6379970B1 (en) | Analysis of differential protein expression | |
US6436640B1 (en) | Use of LNA in mass spectrometry | |
US20020137057A1 (en) | Rapid, quantitative method for the mass spectrometric analysis of nucleic acids for gene expression and genotyping | |
EP1926997A1 (en) | Mass labels | |
WO2005116660A2 (en) | Methods for making and using mass tag standards for quantitative proteomics | |
CN113015740A (zh) | 固相n-末端肽的捕获和释放 | |
EP1356281B1 (en) | Rapid and quantitative proteome analysis and related methods | |
WO1996036737A1 (en) | Parallel multiplex polynucleotide sequencing | |
CN116626189B (zh) | 一种基于LC-MS对On-DNA化学反应中DNA损伤的分析方法 | |
CN115436500B (zh) | 一种可操作切断的dna编码苗头化合物的鉴定方法 | |
CN115436331B (zh) | 一种dna编码苗头化合物活性检测的方法 | |
CN114764089B (zh) | 一种可操作切断的dna编码苗头化合物的鉴定方法 | |
US20020106700A1 (en) | Method for analyzing proteins | |
US20100062538A1 (en) | Identifying and counting proteins in a sample | |
Leitner | Chemical derivatization of peptides for quantitative proteomics | |
Want et al. | Mass spectrometry in high throughput analysis | |
SYNtheSiS | article watch | |
JP2002372517A (ja) | 質量分析法によるタンパク質の構造解析方法 | |
EP1161681A2 (en) | Use of lna in mass spectrometry |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |